Global Cancer Drug Market 2010-2014

Document Sample
Global Cancer Drug Market 2010-2014 Powered By Docstoc
					2010–2014   Global Cancer Drug Market




                             technavio insights
2010–2014                Global Cancer Drug Market




            CONTENTS


            01. Executive Summary ..............................................1
            02. Introduction ...........................................................2

            03. Market Coverage .................................................4

            04. Market Landscape ................................................5

            05. Vendor Landscape ...............................................8

            06. Buying Criteria .....................................................10

            07. Market Growth Drivers ........................................11

            08. Drivers and their Impact .....................................13

            09. Market Challenges .............................................14

            10. Market Trends ......................................................16

            11. Key Vendor Analysis ...........................................18
            11.1 Roche Pharmaceuticals Inc. ............................................. 18

            11.2 AstraZeneca Plc. ................................................................. 20

            11.3 Novartis International AG .................................................. 22

            11.4 Eli Lilly and Co. ..................................................................... 24

            12. Other Reports in this Series .................................26




2010–2014                                                            Global Cancer Drug Market
2010–2014           Global Cancer Drug Market




            EXHIBITS

            Exhibit 1: Global Cancer Drug Market 2010–2014 (US$
                       billion) .....................................................................................5

            Exhibit 2: Global Cancer Drug Market by Geographical
                       Segmentation 2010 ..............................................................6

            Exhibit 3: Global         Cancer           Drug        Market          by      Vendor
                       Segmentation 2010 ..............................................................8




2010–2014                                                               Global Cancer Drug Market
Global Cancer Drug Market                                                                              1

      01. Executive Summary
                                   2010: US$61.1 billion
       Market Size
                                   2014: US$98.2 billion

       Growth Rate                 12.6 percent CAGR

                                   The Americas
       Key Geographies             EMEA
                                   APAC

                                   Hospitals
       Key           Customer
                                   Patients
       Segments
                                   Cancer Research Centers

                                   Increasing Use of a Combination of Therapies for Cancer
                                    Treatment
       Trends                      Outsourcing of Manufacturing of Drugs to China and India
                                   Increasing Numbers of Mergers and Acquisitions in the Market
                                   Collaborative Research for R&D of New Drugs

                                   Increase in the Prevalence of Cancer Worldwide
                                   Reimbursement Support for Cancer Drugs
       Drivers
                                   Increasing Development of Advanced Cancer Drugs
                                   Increase in the Number of Awareness Campaigns

                                   Radiation Therapy and Surgery: Alternative Cancer Treatments
                                   Side Effects Caused by Cancer Drugs
       Challenges
                                   Threat of Counterfeit Cancer Drugs in the Market
                                   Voluntary Product Recalls by Cancer Drug Vendors

                                   Approval for Drugs
       Key Customer Needs          Cost
                                   Results of Clinical Trials

                                   Roche Pharmaceuticals Inc.
                                   AstraZeneca PLC.
       Key Vendors
                                   Novartis International AG
                                   Eli Lilly and Co.




2010–2014                                                                      Global Cancer Drug Market
Global Cancer Drug Market                                                                                  2

      02. Introduction
      Cancer is a disease in which an abnormal cell division starts taking place and invades other
      tissues. The human body is composed of different types of cells, which grow, divide, and multiply
      in a controlled fashion. When cells become old or
				
DOCUMENT INFO
Tags:
Stats:
views:11
posted:3/13/2012
language:Latin
pages:30
Description: TechNavio’s analysts forecast the Global Cancer Drug market to grow at a CAGR of 12.6 percent over the period 2010–2014. One of the key factors contributing to this market growth is the increase in the prevalence of cancer worldwide. The Global Cancer Drug market in the Americas, and the EMEA and APAC region has also been witnessing increasing use of a combination of therapies for cancer treatment. However, presence of alternative cancer treatments such as radiation therapy and surgery could pose a challenge to the growth of this market. TechNavio’s report, the Global Cancer Drug Market 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cancer Drug market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this market space include Roche Pharmaceuticals Inc., AstraZeneca PLC., Novartis International AG and, Eli Lilly and Co. Key questions answered in this report: What will the market size be in 2014 and at what rate will it grow? What key trends is this market subject to? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the opportunities and threats faced by each of these key vendors? What are the strengths and weaknesses of each of these key vendors?
BUY THIS DOCUMENT NOW PRICE: $1500 100% MONEY BACK GUARANTEED
PARTNER Infiniti Research
Infiniti Research provides actionable market intelligence, strategic intelligence, competitive intelligence and customer intelligence to leading companies worldwide. We have extensive access to market information and established contacts with decision makers in the corporate world that we bring to all our projects. Our clients range from rapidly growing start-up's to blue-chip Fortune 500 companies. Our research services cover 50+ countries and we deliver 200+ market research projects every year. TechNavio is the market intelligence platform of Infiniti Research and is built on a foundation of fact-based information and insights drawn from the leaders, doers and influencers of the corporate world.